Assessment report chondroitine sulphate, applicant Gnosis S.p.A.
A report on the initial assessment of chondroitine sulphate by the company Gnosis S.p.A.
The application concerns biosynthetic chondroitine sulphate for use in food supplements.
This report describes a so-called ‘initial assessment’ according to the European approval procedure for novel foods, as governed by European Regulation 258/97.
The Novel Foods Unit sent this assessment report to the Minister for Health, Welfare and Sport on the 23rd of May 2017.